Schiff Nutrition International Acquires Ganeden Biotech for $40M

Schiff Nutrition International, Inc. WNI, through its subsidiary Schiff Nutrition Group, Inc., purchased certain assets and assumed certain liabilities of Ganeden Biotech, Inc. for $40 million in cash utilizing its existing revolving credit facility. Schiff now owns the worldwide exclusive rights to use the leading probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space and the leading brands Sustenex® and Digestive Advantage® under which BC30 is currently sold. Ganeden and Schiff also intend to collaborate on extending the use of probiotic technologies into new areas of human health.